Pfizer and BioNTech have signed an agreement with the European Commission to supply 900 million more doses of their coronavirus vaccine. Deliveries will start in December 2021 and continue until 2023. The agreement also includes an option for 900 million doses. Thus, the total volume of deliveries to Europe since the beginning of the pandemic could reach 2.4 billion doses.
Pfizer and BioNTech have signed an agreement with the European Commission to supply 900 million more doses of their coronavirus vaccine. Deliveries will start in December 2021 and continue until 2023. The agreement also includes an option for 900 million doses. Thus, the total volume of deliveries to Europe since the beginning of the pandemic could reach 2.4 billion doses. 
investors.biontech.de
English (US) 